| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |